Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative
Eliza W. Beal, Shruthi Srinivas, Chengli Shen, Alex Kim, Fabian M. Johnston, Jonathan B. Greer, Daniel E. Abbott, Courtney Pokrzywa, Mustafa Raoof, Travis E. Grotz, Jennifer L. Leiting, Keith F. Fournier, Seán Dineen, Benjamin D. Powers, Jula Veerapong, Anai Kothari, Ugwuji Maduekew, Shishir K. Maithel, Gregory C. Wilson, Sameer H. Patel, Laura Lambert, Sherif Abdel‐Misih, Jordan M. Cloyd
Topics & Concepts
MedicineHyperthermic intraperitoneal chemotherapySurgical oncologyCytoreductive surgeryPeritoneal mesotheliomaPseudomyxoma peritoneiInternal medicineIntraperitoneal chemotherapyOverall survivalChemotherapyGastroenterologyOncologySurvival analysisAdjuvant chemotherapySurgeryMesotheliomaAppendixCancerPathologyPaleontologyOvarian cancerBreast cancerBiologyIntraperitoneal and Appendiceal MalignanciesOccupational and environmental lung diseasesAppendicitis Diagnosis and Management